New Strong Buy Stocks for February 13th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Inhibikase Therapeutics, Inc. IKT: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
Equitrans Midstream Corporation ETRN: This midstream energy company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.
Equitrans Midstream Corporation Price and Consensus
Equitrans Midstream Corporation price-consensus-chart | Equitrans Midstream Corporation Quote
ADMA Biologics, Inc. ADMA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA Biologics Inc Price and Consensus
ADMA Biologics Inc price-consensus-chart | ADMA Biologics Inc Quote
Affirm Holdings, Inc. AFRM: This e-commerce company has seen the Zacks Consensus Estimate for its current year earnings increasing 28.3% over the last 60 days.
Affirm Holdings, Inc. Price and Consensus
Affirm Holdings, Inc. price-consensus-chart | Affirm Holdings, Inc. Quote
Orchid Island Capital, Inc. ORC: This finance company has seen the Zacks Consensus Estimate for its current year earnings increasing 73.7% over the last 60 days.
Orchid Island Capital, Inc. Price and Consensus
Orchid Island Capital, Inc. price-consensus-chart | Orchid Island Capital, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Orchid Island Capital, Inc. (ORC) : Free Stock Analysis Report
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
Equitrans Midstream Corporation (ETRN) : Free Stock Analysis Report
Inhibikase Therapeutics, Inc. (IKT) : Free Stock Analysis Report
Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report